Onconetix, Inc. Announces 1-for-10 Reverse Stock Split
Onconetix, Inc., a biotechnology company specializing in oncology solutions, announced a 1-for-10 reverse stock split effective May 21, 2026. This action aims to meet the Nasdaq minimum bid price requirement, preserving its listing status. The reverse split will consolidate every 10 shares into one, reducing outstanding shares from approximately 11…